Screener
Biogen BIIB Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Biogen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Notes payable and term loan | 7,290.3 | 6,286.8 |
| Deferred tax liability | 945.5 | 507.6 |
| Long-term operating lease liabilities | 264.8 | 290.4 |
| Other long-term liabilities | 820.9 | 748.5 |
| Total liabilities | 13,238.6 | 11,182.7 |
| Commitments, contingencies and guarantees | ||
| Equity: | ||
| Biogen Inc. shareholders’ equity: |
Item 1. Financial Statements (unaudited)
FAQ
- What is Biogen's other non-current liabilities?
- Biogen (BIIB) reported other non-current liabilities of $820.9M in Q2 2026.
- How has Biogen's other non-current liabilities changed year-over-year?
- Biogen's other non-current liabilities increased by 2.7% year-over-year, from $799.6M to $820.9M.
- What is the long-term trend for Biogen's other non-current liabilities?
- Over 5 years (2020 to 2025), Biogen's other non-current liabilities has grown at a -10.9% compound annual growth rate (CAGR), from $1.33B to $748.5M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Biogen's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude